The latest report on CTE is both enlightening and alarming. As the Boston Herald reported, a groundbreaking study from Boston University researchers found that those with CTE have a much higher chance ...

Boston University researchers in a groundbreaking study found that those with CTE have a much higher chance of being diagnosed with dementia. The largest study of its kind from the Boston University ...

Patients with advanced chronic traumatic encephalopathy (CTE), a brain disease likely caused by repeated head injuries, were more than four times as likely to develop dementia compared to those ...

The largest study of its kind from the Boston University CTE Center reveals that chronic traumatic encephalopathy (CTE) should be recognized as a new cause of dementia. The research, published online ...

Forget reducing wrinkles and fighting hair loss. Chronic traumatic encephalopathy (CTE) is often observed in football players due to tackles and falls. Getty Images While it hasn’t been put to the ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

(TNS) — Omar Muñoz trained as a chemical engineer and worked for almost 30 years as an industry executive, most recently in management at Intel Corporation here. Recently, the mid-career professional ...

The Houston ISD board is set to vote Thursday night on sweeping changes to magnet and career and technical education (CTE) programs, a decision that has sparked sharp criticism from parents, educators ...

(TNS) — There is a surge of interest in career and technical education programs at the secondary school level, fueled by concerns about the cost of college and opportunities to make good money in jobs ...

There is a surge of interest in career and technical education programs at the secondary school level, fueled by concerns about the cost of college and opportunities to make good money in jobs that ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...